KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ — Daisy Genomics Inc. (“Daisy Genomics”) and New Day Diagnostics (“New Day”) have announced ...
“Colorectal cancer is the second deadliest cancer in the U.S., yet early detection dramatically improves survival,” says Eric Mayer, CEO of New Day Diagnostics. “With this collaboration, we are one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results